150 related articles for article (PubMed ID: 19479313)
1. Measurement of myocardial fatty acid esterification using [1-11C]palmitate and PET: comparison with direct measurements of myocardial triglyceride synthesis.
Coggan AR; Kisrieva-Ware Z; Dence CS; Eisenbeis P; Gropler RJ; Herrero P
J Nucl Cardiol; 2009; 16(4):562-70. PubMed ID: 19479313
[TBL] [Abstract][Full Text] [Related]
2. Assessment of myocardial triglyceride oxidation with PET and 11C-palmitate.
Kisrieva-Ware Z; Coggan AR; Sharp TL; Dence CS; Gropler RJ; Herrero P
J Nucl Cardiol; 2009; 16(3):411-21. PubMed ID: 19212800
[TBL] [Abstract][Full Text] [Related]
3. Assessment of myocardial metabolism with 11C-palmitate. Comparison with 123I-heptadecanoic acid.
Lerch RA; Bergmann SR
Eur Heart J; 1985 Aug; 6 Suppl B():21-7. PubMed ID: 3878785
[TBL] [Abstract][Full Text] [Related]
4. Acute hyperinsulinemia and reduced plasma free fatty acid levels decrease intramuscular triglyceride synthesis.
Zhang XJ; Wang L; Tuvdendorj D; Wu Z; Rodriguez NA; Herndon DN; Wolfe RR
Metabolism; 2013 Jan; 62(1):44-51. PubMed ID: 22898252
[TBL] [Abstract][Full Text] [Related]
5. Quantitation of myocardial fatty acid metabolism using PET.
Bergmann SR; Weinheimer CJ; Markham J; Herrero P
J Nucl Med; 1996 Oct; 37(10):1723-30. PubMed ID: 8862319
[TBL] [Abstract][Full Text] [Related]
6. Competition between palmitate and ketone bodies as fuels for the heart: study with positron emission tomography.
Vanoverschelde JL; Wijns W; Kolanowski J; Bol A; Decoster PM; Michel C; Cogneau M; Heyndrickx GR; Essamri B; Melin JA
Am J Physiol; 1993 Mar; 264(3 Pt 2):H701-7. PubMed ID: 8456973
[TBL] [Abstract][Full Text] [Related]
7. Efflux of metabolized and nonmetabolized fatty acid from canine myocardium. Implications for quantifying myocardial metabolism tomographically.
Fox KA; Abendschein DR; Ambos HD; Sobel BE; Bergmann SR
Circ Res; 1985 Aug; 57(2):232-43. PubMed ID: 4017196
[TBL] [Abstract][Full Text] [Related]
8. [11C]palmitate kinetics across the splanchnic bed in arterial, portal and hepatic venous plasma during fasting and euglycemic hyperinsulinemia.
Guiducci L; Järvisalo M; Kiss J; Någren K; Viljanen A; Naum AG; Gastaldelli A; Savunen T; Knuuti J; Salvadori PA; Ferrannini E; Nuutila P; Iozzo P
Nucl Med Biol; 2006 May; 33(4):521-8. PubMed ID: 16720244
[TBL] [Abstract][Full Text] [Related]
9. Subcutaneous adipose tissue free fatty acid uptake measured using positron emission tomography and adipose biopsies in humans.
Cao Y; Gathaiya N; Han Q; Kemp BJ; Jensen MD
Am J Physiol Endocrinol Metab; 2019 Aug; 317(2):E194-E199. PubMed ID: 31013145
[TBL] [Abstract][Full Text] [Related]
10. Fatty acids and insulin modulate myocardial substrate metabolism in humans with type 1 diabetes.
Peterson LR; Herrero P; McGill J; Schechtman KB; Kisrieva-Ware Z; Lesniak D; Gropler RJ
Diabetes; 2008 Jan; 57(1):32-40. PubMed ID: 17914030
[TBL] [Abstract][Full Text] [Related]
11. Hyperinsulinemia and skeletal muscle fatty acid trafficking.
Kanaley JA; Shadid S; Sheehan MT; Guo Z; Jensen MD
Am J Physiol Endocrinol Metab; 2013 Aug; 305(4):E540-8. PubMed ID: 23820622
[TBL] [Abstract][Full Text] [Related]
12. Comparison of 1-(11)C-glucose and (18)F-FDG for quantifying myocardial glucose use with PET.
Herrero P; Sharp TL; Dence C; Haraden BM; Gropler RJ
J Nucl Med; 2002 Nov; 43(11):1530-41. PubMed ID: 12411556
[TBL] [Abstract][Full Text] [Related]
13. Fatty acid metabolism in the liver, measured by positron emission tomography, is increased in obese individuals.
Iozzo P; Bucci M; Roivainen A; Någren K; Järvisalo MJ; Kiss J; Guiducci L; Fielding B; Naum AG; Borra R; Virtanen K; Savunen T; Salvadori PA; Ferrannini E; Knuuti J; Nuutila P
Gastroenterology; 2010 Sep; 139(3):846-56, 856.e1-6. PubMed ID: 20685204
[TBL] [Abstract][Full Text] [Related]
14. Validation of 18F-fluoro-4-thia-palmitate as a PET probe for myocardial fatty acid oxidation: effects of hypoxia and composition of exogenous fatty acids.
DeGrado TR; Kitapci MT; Wang S; Ying J; Lopaschuk GD
J Nucl Med; 2006 Jan; 47(1):173-81. PubMed ID: 16391202
[TBL] [Abstract][Full Text] [Related]
15. Selective cannabinoid-1 receptor blockade benefits fatty acid and triglyceride metabolism significantly in weight-stable nonhuman primates.
Vaidyanathan V; Bastarrachea RA; Higgins PB; Voruganti VS; Kamath S; DiPatrizio NV; Piomelli D; Comuzzie AG; Parks EJ
Am J Physiol Endocrinol Metab; 2012 Sep; 303(5):E624-34. PubMed ID: 22761159
[TBL] [Abstract][Full Text] [Related]
16. [Planar scintigraphy versus PET in measuring fatty acid metabolism of the heart].
Kaiser KP; Feinendegen LE
Herz; 1987 Feb; 12(1):41-50. PubMed ID: 3493962
[TBL] [Abstract][Full Text] [Related]
17. Quantification of myocardial glucose utilization by PET and 1-carbon-11-glucose.
Herrero P; Weinheimer CJ; Dence C; Oellerich WF; Gropler RJ
J Nucl Cardiol; 2002; 9(1):5-14. PubMed ID: 11845124
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of 15-(4-(2-[¹⁸F]Fluoroethoxy)phenyl)pentadecanoic acid: a potential PET tracer for studying myocardial fatty acid metabolism.
Tu Z; Li S; Sharp TL; Herrero P; Dence CS; Gropler RJ; Mach RH
Bioconjug Chem; 2010 Dec; 21(12):2313-9. PubMed ID: 21070001
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of reduced myocardial glucose utilization during acute hypertriglyceridemia in rats.
Ménard SL; Ci X; Frisch F; Normand-Lauzière F; Cadorette J; Ouellet R; Van Lier JE; Bénard F; Bentourkia M; Lecomte R; Carpentier AC
Mol Imaging Biol; 2009; 11(1):6-14. PubMed ID: 18769973
[TBL] [Abstract][Full Text] [Related]
20. Ketone Body Infusion With 3-Hydroxybutyrate Reduces Myocardial Glucose Uptake and Increases Blood Flow in Humans: A Positron Emission Tomography Study.
Gormsen LC; Svart M; Thomsen HH; Søndergaard E; Vendelbo MH; Christensen N; Tolbod LP; Harms HJ; Nielsen R; Wiggers H; Jessen N; Hansen J; Bøtker HE; Møller N
J Am Heart Assoc; 2017 Feb; 6(3):. PubMed ID: 28242634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
